Nuzenio

Tipranks Tenax Therapeutics

Tipranks Tenax Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Tenax Therapeutics downgraded to In Line from Outperform at Evercore ISI - TipRanksTipRanks · Mon, 10 Aug 2026 20:29:48 GMTTenax Therapeutics downgraded to Market Perform from Outperform at William Blair - TipRanksTipRanks · Mon, 10 Aug 2026 17:13:14 GMTTenax Therapeutics price target lowered to $5 from $30 at Roth Capital - TipRanksTipRanks · Mon, 10 Aug 2026 14:36:16 GMTTenax Therapeutics reports LEVEL trial did not meet primary endpoint - TipRanksTipRanks · Mon, 10 Aug 2026 13:24:02 GMTTenax Therapeutics Phase 3 LEVEL Trial Topline Results - TipRanksTipRanks · Mon, 10 Aug 2026 11:53:35 GMTChardan Capital Initiates a Buy Rating on Tenax Therapeutics (TENX) - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 20:50:00 GMTChardan Capital Initiates Tenax Therapeutics(TENX.US) With Buy Rating, Announces Target Price $27 - MoomooMoomoo · Fri, 31 Jul 2026 20:31:00 GMTTenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market - TipRanksTipRanks · Fri, 31 Jul 2026 18:41:09 GMT

Timeline

Mon, 10 Aug 2026 20:29:48 GMTTenax Therapeutics downgraded to In Line from Outperform at Evercore ISI - TipRanks
Mon, 10 Aug 2026 17:13:14 GMTTenax Therapeutics downgraded to Market Perform from Outperform at William Blair - TipRanks
Mon, 10 Aug 2026 14:36:16 GMTTenax Therapeutics price target lowered to $5 from $30 at Roth Capital - TipRanks
Mon, 10 Aug 2026 13:24:02 GMTTenax Therapeutics reports LEVEL trial did not meet primary endpoint - TipRanks
Mon, 10 Aug 2026 11:53:35 GMTTenax Therapeutics Phase 3 LEVEL Trial Topline Results - TipRanks
Sat, 01 Aug 2026 20:50:00 GMTChardan Capital Initiates a Buy Rating on Tenax Therapeutics (TENX) - The Globe and Mail

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Tenax Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.